Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rilpivirine Switch from Nevirapine in Virologically Suppressed HIV Patients
NCT03664440Phase 4Completed
- Sponsor
- Mahidol University
- Start
- Dec 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rilpivirine in human immunodeficiency virus infection (HIV), sponsored by Mahidol University. Started Dec 2016; status: completed.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03664440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03664440.